Author:
Kancharla Harish,Gundu Naresh,Pathak Neha,Vandidassane Ilavarasi,Khurana Sachin,Pushpam Deepam,Jain Deepali,Kumar Sunil,Pathy Sushmita,Mohan Anant,Malik Prabhat Singh
Reference25 articles.
1. International Agency for Research in Cancer, Latest global cancer data: cancer burden rises to 18.1 million new cases and 9.6 million cancer deaths in 2018. https://www.iarc.fr/featured-news/latest-global-cancer-data-cancer-burden-rises-to-18-1-million-new-cases-and-9-6-million-cancer-deaths-in-2018/ (Accessed November 29, 2019).
2. N. Howlader, A.M. Noone, M. Krapcho M, D. Miller, K. Bishop, C.L. Kosary, et al, SEER cancer statistics review, 1975-2010. http://seer.cancer.gov/csr/1975_2010. (Accessed November 29, 2019).
3. Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: final results of a phase III trial;Socinski;J Clin Oncol,2012
4. What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis;Bronte;Crit Rev Oncol Hematol,2015
5. Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial;Gridelli;J Natl Cancer Inst,2003
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献